Chromatin context-dependent regulation and epigenetic manipulation of prime editing
- PMID: 38608704
- PMCID: PMC11088515
- DOI: 10.1016/j.cell.2024.03.020
Chromatin context-dependent regulation and epigenetic manipulation of prime editing
Abstract
We set out to exhaustively characterize the impact of the cis-chromatin environment on prime editing, a precise genome engineering tool. Using a highly sensitive method for mapping the genomic locations of randomly integrated reporters, we discover massive position effects, exemplified by editing efficiencies ranging from ∼0% to 94% for an identical target site and edit. Position effects on prime editing efficiency are well predicted by chromatin marks, e.g., positively by H3K79me2 and negatively by H3K9me3. Next, we developed a multiplex perturbational framework to assess the interaction of trans-acting factors with the cis-chromatin environment on editing outcomes. Applying this framework to DNA repair factors, we identify HLTF as a context-dependent repressor of prime editing. Finally, several lines of evidence suggest that active transcriptional elongation enhances prime editing. Consistent with this, we show we can robustly decrease or increase the efficiency of prime editing by preceding it with CRISPR-mediated silencing or activation, respectively.
Keywords: DNA damage repair; cis x trans interactions; cis-chromatin effect; epigenome editing; genome engineering; prime editing.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests J.S. is an SAB member, consultant and/or co-founder of Prime Medicine, Cajal Neuroscience, Guardant Health, Maze Therapeutics, Camp4 Therapeutics, Phase Genomics, Adaptive Biotechnologies, Scale Biosciences, Sixth Street Capital, and Pacific Biosciences. University of Washington has filed a provisional patent application based on this work on which J.S., X.L., W.C., and J.C. are co-inventors.
Figures







Update of
-
Chromatin context-dependent regulation and epigenetic manipulation of prime editing.bioRxiv [Preprint]. 2023 Apr 12:2023.04.12.536587. doi: 10.1101/2023.04.12.536587. bioRxiv. 2023. Update in: Cell. 2024 May 9;187(10):2411-2427.e25. doi: 10.1016/j.cell.2024.03.020. PMID: 37090511 Free PMC article. Updated. Preprint.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials